Glaxo to Acquire Human Genome Sciences (HGSI) for $14 a Share

British pharmaceutical giant GlaxoSmithKline (GSK) is expected to announce an agreement to acquire Rockville, Maryland – based Human Genome Sciences Inc. (HGSI) for about $2.8 billion, or $14 a share, sweetening the offer from its previous $13 per share bid, Reuters reported, citing two people familiar with the situation. The proposed cash purchase, which would give Glaxo [...]